Evidence map›Paper›PMID 28244597›Full record

ArticleClinical cardiology2017

Interleukin-37 elevation in patients with atrial fibrillation.

Weidong Li, Shijie Li, Xianjin Li, Shuzhong Jiang, Bing Han

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Association of theDiagnostics (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Weidong LiDepartment of Cardiology, Xuzhou Central Hospital, Jiangsu, PR China.
Shijie LiDepartment of Cardiology, Xuzhou Central Hospital, Jiangsu, PR China.
Xianjin LiDepartment of Cardiology, Xuzhou Central Hospital, Jiangsu, PR China.
Shuzhong JiangDepartment of Cardiology, Xuzhou Central Hospital, Jiangsu, PR China.
Bing HanDepartment of Cardiology, Xuzhou Central Hospital, Jiangsu, PR China.
Xuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammation is closely related to atrial fibrillation (AF) pathogenesis, and interleukin-37 (IL-37) represents a new member of the anti-inflammatory cytokines. HYPOTHESIS: IL-37 might play an important role in AF development and act as a potential risk factor for AF diagnosis.

methodsThe mRNA level of IL-37 in peripheral blood mononuclear cells (PBMCs) and serum IL-37 levels in AF patients and healthy controls were measured by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). PBMCs from AF patients were stimulated with recombinant IL-37. Levels of pro-inflammatory cytokines IL-6 and C-reactive protein were determined by RT-PCR and ELISA.

resultsIL-37 mRNAs and serum protein levels were higher in patients with AF or lone AF compared with healthy controls. Patients with paroxysmal AF or persistent AF showed higher IL-37 mRNAs and serum protein levels compared with those with permanent AF as well as healthy controls. In vitro, IL-37 inhibited the production of IL-6 and C-reactive protein in PBMCs of patients with AF.

conclusionsIL-37 is elevated in AF patients and its expression is closely associated with AF subgroups. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of AF. This study is the first to document elevated IL-37 in AF patients.

Indexed as

Gene Expression RegulationAtrial FibrillationCells, CulturedEnzyme-Linked Immunosorbent AssayFollow-Up StudiesHumansInflammationInterleukin-1Leukocytes, MononuclearProspective StudiesReal-Time Polymerase Chain ReactionRNA, MessengerIL37 protein, humanInterleukin-1RNA, MessengerAFAtrial FibrillationIL-37InflammationInterleukin-37

Identifiers

PMID28244597
PMCPMC6490375
OpenAlexW2547848368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.